Entrectinib approval by EMA reinforces options for ROS1 and...

Entrectinib approval by EMA reinforces options for ROS1 and tumour agnostic NTRK targeted cancer therapies

Ardini, Elena, Siena, Salvatore
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
5
Journal:
ESMO Open
DOI:
10.1136/esmoopen-2020-000867
Date:
September, 2020
File:
PDF, 976 KB
2020
Conversion to is in progress
Conversion to is failed